NCT00655863 - Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Diabetes Mellitus

Interventions

DRUG

Alogliptin and Pioglitazone

Alogliptin 25 mg, tablets, orally, once daily and pioglitazone 30 mg, tablets, orally, once daily for up to 16 weeks.

DRUG

Alogliptin

Alogliptin 25 mg, tablets, orally, once daily and pioglitazone placebo-matching tablets, orally, once daily for up to 16 weeks.

DRUG

Placebo

Alogliptin placebo-matching tablets, orally, once daily and pioglitazone placebo-matching tablets, orally, once daily for up to 16 weeks.

Trial Locations (2)

Amsterdam

Gothenburg